NCT04031898View on ClinicalTrials.gov

Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)

CompletedOBSERVATIONAL

Enrollment

896

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions

Lung Cancer

Interventions

OTHER

Non Interventional

This is a non interventional, observational, retrospective study including patients with EGFR-mutated advanced NSCLC, treated with 1st or 2nd generation EGFR TKI therapy in first line

Trial Locations (1)

1140

Research Site, Wien